Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn ways to build wealth even if you don't have a high income. Start your wealth-building journey today with practical strategies!
26,798 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A niche AI hardware stock is drawing investors as hyperscale data centers surge. Analysts say this stock could easies...
Japan’s Toto, the top bidet maker, has long supplied precision chip components. Now investors are connecting Toto to ...
Two giants in the U.S. cannabis space face off for investors: Green Thumb Industries and Curaleaf. This guide breaks ...
IREN stock surge propels the stock higher as the company pivots to AI cloud infrastructure and signs multi-billion de...
A late-appeal by a U.S. president over Balogun’s red card has thrown FIFA's neutrality into the spotlight, with poten...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
MongoDB stock is under pressure again, with shares dropping sharply amid a broad market sell-off. This article breaks...
Applied Optoelectronics shares climbed after a strong quarterly showing and renewed appetite for laser transceivers f...
Ripple (XRP) traders are eyeing a potential return to its 2025 peak of $3.65, even as the token trades near $1.45. Ke...
Microsoft posts solid Q3 results, showing AI and cloud momentum that investors say could unlock value in Big Tech. Th...
A 15-year view of Alphabet shows how a modest initial bet could compound amid AI and cloud expansion, delivering a po...